SAFEWATER Health & Behaviour Impact Field Trials; Colombia (SAFEWATER)

October 14, 2021 updated by: University of Ulster

The Health and Behavioural Impact of Implementing SAFEWATER Systems for Drinking Water Disinfection Within Rural Communities in Colombia and Mexico; Colombia.

At least 1.8 billion people globally use a source of drinking water that is faecally contaminated and thus likely to lead to diarrheal illness: nearly 1,000 children die each day due to water and sanitation-related diarrhoeal diseases. Diseases related to the consumption of contaminated drinking-water place a major burden on human health. In 2017, 785 million people still lacked access to an improved drinking water source, and these are mostly the poor and marginalised. Almost a quarter of those people rely on surface water that is untreated and over 90% live in rural areas. Many people are forced to rely on sources that are microbiologically unsafe, leading to a higher risk of contracting waterborne diseases, including typhoid, hepatitis A and E, polio and cholera. The objectives of the SAFEWATER project is to develop technologies to provide clean water to economically deprived communities in rural Colombia and Mexico. These water technologies will be tested under real conditions with the cooperation of the rural communities.

The SAFEWATER field trials aims to evaluate the health and behaviour impacts of implementing SAFEWATER water treatment technologies for drinking water disinfection, with a behavioral change intervention, within rural communities in Colombia and Mexico

The project has three specific objectives:

  1. Assess water quality improvement at household level
  2. Assess behaviors and test behavioral interventions'
  3. Assess child growth and related health outcomes

Three communities in Colombia and one community in Mexico were recruited to take part in the study. Communities were selected based on factors such as current availability of clean water, accessibility, safety, community size and current activities within the communities.

Pilot and feasibility studies were carried out prior to commencing field trials, thus the design of the trials vary across countries.

Mexico field trial: The trial in Mexico will use a stepped-wedge design, randomized at household level over a 12-month period (6-12 steps dependent on adherence and feasibility). All households (max n200) willing to be involved will be recruited (separate clinicaltrials.gov registration).

Colombia field trial: the trial in Colombia will use a non-randomized parallel design (2:1; intervention:control). A maximum of 84 households (54:30; intervention:control) will be recruited to take part, with families with young children (<12 years) prioritized.

Outcomes for both countries will include 1) water quality, 2) water-related behaviour (e.g. frequency of system use, uses of treated / raw water), and 3) health, e.g. diarrhoea prevalence, growth (height/weight), school attendance, water insecurity status, gut integrity.

Impact: The development and deployment of the SAFEWATER technology has the potential to impact on clean drinking water access for participating communities in Mexico and Colombia, and subsequently on the health and wellbeing of those individuals involved. Additionally if successful, the work will also provide an evidence based model for the provision of improved access to clean drinking water for rural communities in developing regions more widely.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

84

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Medellín, Colombia
        • Centro de Ciencia y Tecnologia de Antioquia (CTA),
    • Antioquia
      • Medellín, Antioquia, Colombia
        • Universidad de Medellin
    • Chipas
      • San Cristóbal de las Casas, Chipas, Mexico, CP 29246
        • Fundación Cántaro Azul, A.C

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Communities in rural communities without access to clean water systems
  • Households where the head of the household fully understands the study information provided and is willing to provide consent.
  • Households where it is feasible to install the SAFEWATER system

Priority Criteria:

  1. Having at least one child of 12 years or under in the household
  2. Having previously worked with Universidad de Medellin or CTA (criteria #2 will only be implemented if households meeting #1 is exhausted)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention community
Two communities in rural Colombia
A domestic water purification technology, consisting of a raw water storage tank, a pump, a filtration unit (2 cartridge filters), a UVC disinfection unit (UV lamp), a storage tank for drinking water (treated and safe water), and a distribution network inside the house for drinking water.
Targeting behaviors around the use of the technology and water more generally. Behavioral interventions will be data-driven (i.e., dependent on the problems that arise) but are likely to include household and community-level activities.
No Intervention: Control community
One community in rural Colombia

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Child (12 years and under) growth
Time Frame: Change over 12 months
Change in BMI percentile to identify stunting, wasting and underweight
Change over 12 months
Water quality
Time Frame: Change over 12 months
Microbial load
Change over 12 months
Use of safe water
Time Frame: Change over 12 months
Frequency
Change over 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Handwashing with soap
Time Frame: Change over 12 months
Frequency
Change over 12 months
Fetching water
Time Frame: Change over 12 months
Frequency
Change over 12 months
School attendance
Time Frame: Change over 12 months
Absence (days)
Change over 12 months
Household water insecurity status
Time Frame: Change over 12 months
The Household Water Insecurity Experiences (HWISE) Scale (scores 0-36 (higher scores indicate greater insecurity))
Change over 12 months
Gut integrity
Time Frame: Change over 12 months
Fingerprick test for iron levels in a sub-group of children as a proxy marker of improved gut integrity.
Change over 12 months
Water quality
Time Frame: Change over 12 months
Turbidity (measured using a turbidimeter (NTU units)
Change over 12 months
Use of safe water
Time Frame: Change over 12 months
Practices for drinking, hygiene and cooking i.e. what the water is used for and how
Change over 12 months
Use of the system
Time Frame: Change over 12 months
Frequency; intervention group only
Change over 12 months
Use of the system
Time Frame: Change over 12 months
Practices; intervention group only i.e. what the water is used for and how
Change over 12 months
Untreated water usage
Time Frame: Change over 12 months
Frequency
Change over 12 months
Untreated water usage
Time Frame: Change over 12 months
Practices for drinking, hygiene and cooking i.e. what the water is used for and how
Change over 12 months
Water storage practices
Time Frame: Change over 12 months
Frequency
Change over 12 months
Water storage practices
Time Frame: Change over 12 months
Method
Change over 12 months
Sharing of safe water to external households
Time Frame: Change over 12 months
Intervention group only. Frequency and volume of water shared with external households
Change over 12 months
Diarrhoea prevalence
Time Frame: Change over 12 months
Bristol Stool Chart (Type 1(hard) - 7(soft)
Change over 12 months
Maintenance to SAFEWATER system
Time Frame: Change over 12 months
Frequency (intervention group only)
Change over 12 months
Maintenance to SAFEWATER system
Time Frame: Change over 12 months
Nature of maintenance; intervention group only
Change over 12 months
Satisfaction of SAFEWATER system
Time Frame: Change over 12 months
Level of satisfaction for system and water provided, including taste, colour & temperature and odour (1(satisfied) - 3(unsatisfied)) + reasons (qualitative)
Change over 12 months
Making unplanned changes to the system
Time Frame: Change over 12 months
Making changes for functional or aesthetical reasons which could potentially interfere with the functioning of the system (list of changes / household) - intervention group only
Change over 12 months
Study retention
Time Frame: Change over 12 months
Percentage completed appointments
Change over 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2021

Primary Completion (Anticipated)

April 30, 2022

Study Completion (Anticipated)

April 30, 2022

Study Registration Dates

First Submitted

January 20, 2021

First Submitted That Met QC Criteria

March 31, 2021

First Posted (Actual)

April 2, 2021

Study Record Updates

Last Update Posted (Actual)

October 20, 2021

Last Update Submitted That Met QC Criteria

October 14, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Water-Related Diseases

Clinical Trials on SAFEWATER systems for drinking water disinfection

3
Subscribe